PAR2: Use of Respiratory Assist Devices by Medicare Beneficiaries (English)
- New search for: Silverman, B. G.
- New search for: Silverman, B. G.
In:
VALUE IN HEALTH
;
4
, 2
;
75
;
2001
-
ISSN:
- Article (Journal) / Print
-
Title:PAR2: Use of Respiratory Assist Devices by Medicare Beneficiaries
-
Contributors:Silverman, B. G. ( author )
-
Published in:VALUE IN HEALTH ; 4, 2 ; 75
-
Publisher:
- New search for: VALUE IN HEALTH
-
Publication date:2001-01-01
-
Size:75 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 610
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 610 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 4, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 47
-
EM1: Risk Attitude: Association With Magnitude Of Risk and Patient CharacteristicsSinger, M. E. / Beaird, H. / Miller, L. A. N. et al. | 2001
- 47
-
EM2: The Impact of Hospital Costing Methods on Statistical Power in Multinational Clinical TrialsReed, S. D. / Friedman, J. Y. / Malenbaum, J. H. / Gnanasakthy, A. / Schulman, K. A. et al. | 2001
- 48
-
EM4: Can Unit Costs Be Compared Across Western European Countries?Brown, R. / Hutton, J. / Nuijten, M. et al. | 2001
- 48
-
EM3: Response Bias Among Likely Clinical Trial ParticipantsMcDonnell, D. D. / Donohue, J. A. et al. | 2001
- 48
-
MD1: Cost-Effectiveness of Airline Defibrillators: Is Peace of Mind More Important Than Saving Lives?Cram, P. / Vijan, S. / Wolbrink, A. M. / Fendrick, A. M. et al. | 2001
- 49
-
MD4: Inclusion of Indirect Cost in Economic Outcomes Analyses of Medical Devices: How Important Is It?Subramanian, S. / Justason, B. J. et al. | 2001
- 49
-
MD3: The Diagnostic Accuracy of 18FDG-PET In Patients With Recurrent Papillary or Follicular Thyroid Cancer: A Systematic ReviewHooft, L. / Hoekstra, O. S. et al. | 2001
- 49
-
MD2: Analysis of The Impact of Assistive Living Devices on Self-Assessed Health Status RatingRodney, A. B. / Xiao, H. / Robertson, T. et al. | 2001
- 50
-
QL1: Does Socioeconomic Status Affect The Valuation Of Health?Asada, Y. / Stout, N. K. / Kind, P. et al. | 2001
- 50
-
QL2: Logical Consistency and the Valuation of Health: An Analysis Of US Survey DataCraig, B. M. / Kind, P. et al. | 2001
- 51
-
HP1: Ethnic Disparity of Combination Ribavirin/Interferon Alfa-2b Prescribing Among Hepatitis C-Infected Members in a Managed Care Organization (MCO)Phillips, A. L. / Schaffer, M. / Mansukani, S. et al. | 2001
- 51
-
QL3: Quality Of Life in Product Labeling: A Review of Marketed Drug ProductsChopra, T. / Shah, S. N. / McLaughlin-Miley, C. / Hinton, J. et al. | 2001
- 51
-
QL4: Quality Of Life Messages in Prescription Drug Advertisements in Leading Medical Journals, 1990-99Zivin, K. / Neumann, P. et al. | 2001
- 52
-
HP2: The Role Of Outlier Payments in Medicare Patients with Severe SepsisCooper, L. M. / Linde-Zwirble, W. T. et al. | 2001
- 52
-
HP3: Incorporating Clinical Outcomes and Economic Consequences into Drug Formulary Decisions: Evaluation of 30 Months of ExperienceAtherly, D. E. / Sullivan, S. D. / Fullerton, D. S. / Sturm, L. L. et al. | 2001
- 53
-
HP4: Assessing Lifestyle Drugs for Drug Benefit Formularies: A Cost-Utility Analysis Of Orlistat and Sibutramine for the Treatment of Obesity in AdultsTrakas, K. / Oh, P. / Leiter, L. / Shear, N. H. et al. | 2001
- 53
-
CN1: Utilities of Metastatic Breast Cancer Patients (PT) Treated With Taxanes Compared to Utilities of Oncology Nurses (NUR)Hauser, R. / Theriault, R. / Wilson, J. / Shepherd, M. / Lawson, K. / Koeller, J. et al. | 2001
- 53
-
CN2: Effect of Including (Versus Excluding) Fates Worse Than Death on Utility MeasurementFranic, D. M. / Pathak, D. S. et al. | 2001
- 54
-
CN3: Cost-Effectiveness Analysis of Irinotecan+5FU/FA Alone as First-Line Therapy in Advanced Colorectal Cancer in the UKBrown, R. / Sorensen, S. / Burrell, A. / Bearne, A. et al. | 2001
- 54
-
CN4: Economic Evaluation of Gemzar/Cisplatin Relative to Other Cisplatin Based Treatments for Non Small Cell Lung (NSCLC) Cancer In The UKBotwood, N. / McKendrick, J. / Aristides, M. / Lees, M. / Maniadakis, N. / Wein, W. / Stephenson, D. et al. | 2001
- 55
-
CV2: Indirect Comparisons of Drugs Using Meta-Analysis: Validation of ResultsRoss, S. D. / Klawansky, S. / Allen, I. E. et al. | 2001
- 55
-
CV3: Do Short-Acting Opiates in Off-Pump Bypass Surgery Reduce Length of Stay or Total Hospital Costs?Reddy, P. / Feret, B. / Kulicki, L. / Jordan, S. / Donahue, S. / Quercia, R. et al. | 2001
- 55
-
CV1: The Value of Compliance: Evidence From Two Patient CohortsMcGuigan, K. A. / Sokol, M. / Yao, J. / Haynes, J. / Qian, Q. / Boscarino, J. / Epstein, R. et al. | 2001
- 56
-
CV5: The Cost-Effectiveness of Lifetime Factor VIII Prophylaxis in the Treatment of Severe Hemophilia ACharles, R. A. / Hay, J. et al. | 2001
- 56
-
CV4: Using UK Observational Data to Identify Possibilities for the Cost-Effective Improvement of the Treatment Of Atrial FibrillationPiercy, J. / James, P. / Baum, D. / Kuester, L. et al. | 2001
- 57
-
CV7: Cost-Effectiveness of Cardiovascular Disease (CVD) Prevention by Reducing Postprandial HyperglycemiaGlick, H. / Qiao, Q. / Grueger, J. et al. | 2001
- 57
-
CV8: Work-Related Outcomes of Patients Six Months After Myocardial InfarctionErickson, S. R. / McBurney, C. R. / Kline-Rogers, E. M. / Cooper, J. V. / Mani, O. C. M. / Eagle, K. A. et al. | 2001
- 57
-
CV6: Economic Evaluation of Dalteparin, Enoxaparin and Unfractionated Heparin in the Treatment of Deep Vein ThrombosisRisebrough, N. A. / Mittmann, N. et al. | 2001
- 58
-
DG1: The Relationship of Diabetes Symptoms and Health-Related Quality Of LifePfalzgraf, A. R. / Nau, D. P. et al. | 2001
- 58
-
DG2: The Incremental Cost of Diabetes in Chronic Illness Co-OccurrencesGaris, R. I. / Farmer, K. C. / Arora, M. et al. | 2001
- 59
-
DG4: Disease Severity Determines Cost of Gastroesophageal Reflux Disease in a Midwest USA Health Care PlanBrelje, T. / Heaton, A. / Martin, S. / Bhattacharjya, A. / Dodd, S. / Thornhill, J. et al. | 2001
- 59
-
DG3: A Retrospective Evaluation of Nonsteroidal Anti-Inflammatory Drug-Induced Gastrointestinal Complications Among Adults in a Managed Care Health PlanDodd, M. A. / D Angio, R. / Gupchup, G. V. / Nelson, C. et al. | 2001
- 59
-
ID1: Development of a Stochastic Decision Analysis Model of Treatment of Pyelonephritis from the Results of an RCTDavey, P. / Wang, J. / Claxton, K. / Fenwick, E. / Sculpher, M. / Talan, D. et al. | 2001
- 60
-
ID2: Health Values for the Lipodystrophy SyndromeLenert, L. A. / Fedderson, M. / Sturley, A. / Lee, D. et al. | 2001
- 60
-
ID3: Cost-Effectiveness Analysis of An Intranasal Influenza Vaccine for Healthy ChildrenLuce, B. / Zangwill, K. / Palmer, C. / Mendelman, P. / Yan, L. / Wolff, M. / Cho, I. / Iacuzio, D. / Belshe, B. et al. | 2001
- 61
-
MH1: The Impact of Second-Generation Antipsychotic Medications on Ambulatory Patients With SchizophreniaMulani, P. M. / McCombs, J. et al. | 2001
- 61
-
ID4: The Confusion Between Septicemia and Severe SepsisLinde-Zwirble, W. T. / Ball, D. E. / Cooper, L. M. / Lidicker, J. / Angus, D. C. et al. | 2001
- 61
-
MH2: Future Employability: A New Approach to Cost-Effectiveness Analysis of Antipsychotic TherapyGanguly, R. / Miller, L. S. / Martin, B. C. et al. | 2001
- 62
-
MH3: Clinical Assessment of Quality of Life Among Schizophrenia Patients With Deficit SyndromeRusso, P. / Kirkpatrick, B. et al. | 2001
- 62
-
MH4: Application of the Rasch Model to the SF36 Mental Health 5 Item Scale (MH5)Perneger, T. V. / Bovier, P. A. et al. | 2001
- 63
-
MS3: Correlation of a Generic Health-Related Quality of Life Questionnaire and Self-Administered Rheumatoid Arthritis Disease Activity InstrumentKim, S. S. / Drabinski, A. M. / Williams, G. R. / Formica, C. A. et al. | 2001
- 63
-
MS1: Cost-Effectiveness of Interventions For Lateral Epicondylitis: Results from a Randomized Controlled Trial in Primary CareKorthals-de Bos, I. B. C. / Smidt, N. / Tulder, M. / Bouter, L. et al. | 2001
- 63
-
MS2: Responsiveness to Change of the SF-36 in Rapolo, a Longitudinal Study of Rheumatoid Arthritis Patients Treated With EtanerceptLubeck, D. P. / Yelin, E. / Katz, P. / Roepke, L. / Wanke, L. A. / Buatti, M. et al. | 2001
- 64
-
MS4: A Systematic Review of Health State Values for Osteoporosis Related ConditionsBrazier, J. E. / Green, C. / Kanis, J. et al. | 2001
- 64
-
RS1: Outcome Assessment in Pediatric Asthma: A Comparison of Symptom-Free Time and Multi-Attribute ScaleChiou, C. F. / Weaver, M. R. / Bell, M. A. et al. | 2001
- 65
-
RS2: Using Self-Administered Direct TTO Questions to Elicit Utility Values for Asthmatic Patients With Different Severity of DiseaseSzende, A. / Meszaros, A. / Berta, G. Y. / Stahl, E. / Svensson, K. et al. | 2001
- 65
-
RS4: A Model-Based Evaluation of Inhaled Steroids in Mild-To-Moderate AsthmaPaltiel, A. / Fuhlbrigge, A. / Kitch, B. / Weiss, S. / Neumann, P. / Kuntz, K. et al. | 2001
- 65
-
RS3: Psychometric Evaluation of the CAP-SYM Questionnaire: A New, Patient-Based Measure of Symptoms in Community Acquired PneumoniaLamping, D. / Schroter, S. / Sagnier, P. P. / Duprat-Lomon, I. et al. | 2001
- 66
-
PAM1: Joint Counts in Patients with New Onset Rheumatoid Arthritis: Patient vs. Physician AssessmentKim, S. S. / Drabinski, A. M. / Williams, G. R. / Formica, C. A. et al. | 2001
- 66
-
PAM2: An Economic Evaluation of Osteoporosis Medication Use Patterns in a Managed Care Organization: A Time to Fracture AnalysisChen, K. S. / White, T. J. / Chang, E. et al. | 2001
- 67
-
PAM4: Use of COX 2 NSAIDS in Subjects Without Risk of Gastrointestinal Side EffectsHarley, C. R. et al. | 2001
- 67
-
PAM5: Investigating the Construct Validity of a Disease Specific and a General Quality of Life Instruments of Patients with Rheumatoid ArthritisLovas, K. / Szende, A. / Balint, G. / Szebenyi, B. / Hejj, G. et al. | 2001
- 67
-
PAM3: The Cost of Osteoporotic Fractures in the United KingdomBurge, R. T. / Worley, D. / Johansen, A. / Bose, U. et al. | 2001
- 68
-
PAM6: Cost-Effectiveness of Rofecoxib Versus NSAIDs in the Treatment of OsteoarthritisSullivan, P. / Hay, J. et al. | 2001
- 68
-
PAM8: Cost Comparison of Treating Osteoporosis Patients with Estrogens or Selective Estrogen Receptor Modulator in a Managed Care PopulationLiao, E. / Sweazy, L. / Huse, D. et al. | 2001
- 68
-
PAM7: The Correlation Between Arthritis Specific Measures and SF-36 Scales in Rheumatoid Arthritis PatientsLubeck, D. P. / Yelin, E. / Katz, P. / Roepke, L. / Wanke, L. A. / Buatti, M. et al. | 2001
- 69
-
PAM9: Cost Comparison of Treating Rheumatoid Arthritis Patients with COX-2 Inhibitors or NSAIDs in a Managed Care PopulationLiao, E. / Kester, G. / Huse, D. et al. | 2001
- 69
-
PAM10: The Impact of Early Rheumatoid Arthritis on ProductivityKim, S. S. / Drabinski, A. M. / Williams, G. R. / Formica, C. A. et al. | 2001
- 70
-
PAM13: A Cost-Effectiveness Model Comparing Celecoxib and Rofecoxib to Traditional NSAIDs for Osteoarthritis TreatmentSchaefer, M. G. / Morreale, A. P. / Plowman, B. K. et al. | 2001
- 70
-
PAM11: Applying Background Risk Distribution to Evaluate the Cost-Effectiveness of Three Preventive Drug Therapies for Osteoporotic FracturesGao, X. / Madhavan, S. / Nau, D. / Ambegaonkar, A. / Islam, S. / Rosenbluth, S. / Amonkar, M. et al. | 2001
- 70
-
PAM12: Cost-Minimization Analysis of the Treatment of Rheumatoid Arthritis with Leflunomide in Comparison with the Combination of Infliximab and MethotrexateRubio-Terres, C. / Dominguez-Gil, A. et al. | 2001
- 71
-
PAM15: Evaluating Direct and Indirect Measures of Utility: Stability of the SF-6D in a Rheumatoid Arthritis PopulationCrawford, B. / Brazier, J. E. et al. | 2001
- 71
-
PAM14: Treatment with Leflunomide Improves the Utility of Patients with Active Rheumatoid Arthritis: An Application of the SF-6DCrawford, B. / Brazier, J. E. / Strand, V. / Doyle, J. et al. | 2001
- 71
-
PAM16: Cost Impact of COX-2 Inhibitors in a Managed Care Plan: Implications for Formulary Decision-MakingAtherly, D. E. / Fullerton, D. S. / Sturm, L. L. / Bryant, A. / Sullivan, S. D. et al. | 2001
- 72
-
PAM18: Performance Assessment of Two Fatigue Instruments in an Early Rheumatoid Arthritis CohortDrabinski, A. / Kim, S. S. / Williams, G. / Formica, C. et al. | 2001
- 72
-
PAM17: Important Issues in Number Needed to Treat Analysis in Osteoporosis TreatmentKemner, J. E. et al. | 2001
- 73
-
PAM20: Cost-Effectiveness of Acetylcisteine and Dimethylsulphoxide (DMSO) 50% for the Treatment of Patients with Reflex Sympathic Dystrophyvan Dieten, H. E. / Perez, R. S. / Tulder, M. W. / Boers, M. / Zuurmond, W. W. / de Lange, J. J. / Vondeling, H. et al. | 2001
- 73
-
PAM21: Manual Therapy is More Cost-Effective than Physical Therapy and GP Care for Patients with Neck PainKorthals-de Bos, I. B. / Hoving, J. / Tulder, M. / Bouter, L. et al. | 2001
- 73
-
PAM19: A Review of Functional Status Measures for Workers with Upper Extremity DisordersSalerno, D. F. / Copley-Merriman, C. / Taylor, T. N. / Shinogle, J. / Schulz, R. M. et al. | 2001
- 74
-
PAM22: Studying Predictors of Fractures Among Omnicare Nursing Home ResidentsOderda, G. M. / Gause, D. / Stuart, B. / Erwin, G. et al. | 2001
- 74
-
PAM23: Vertebral Fractures Among Glucocorticoid Patients Significantly Increase Medical Care CostsMeyer, J. W. / Burge, R. T. / Steinbuch, M. et al. | 2001
- 75
-
PAR1: Cost of Asthma in Children in VladivostokProsekova, E. / Geltzer, B. / Dercach, V. / Bogdanovskiy, P. et al. | 2001
- 75
-
PAR2: Use of Respiratory Assist Devices by Medicare BeneficiariesSilverman, B. G. et al. | 2001
- 75
-
PAR3: The Standardized Asthma-Related Quality of Life Questionnaire (AQLQ-S): Does Socioeconomic Status Effect Measurements?Lynd, L. D. / Guh, D. / Pare, P. / Anis, A. et al. | 2001
- 76
-
PAR4: Comparison of Two Quality of Life Instruments in Patients with Chronic Obstructive Pulmonary DiseaseAubert, R. E. / Alemayehu, B. / Feifer, R. et al. | 2001
- 76
-
PAR5: Direct and Indirect Costs of Respiratory InfectionsBirnbaum, H. G. / Morley, M. A. / Greenberg, P. E. / Cifaldi, M. / Colice, G. L. et al. | 2001
- 77
-
PAR8: A Cost-Effectiveness Analysis Comparing Levalbuterol and Albuterol in the Treatment of Moderate to Severe AsthmaCarter, C. T. / McGee, M. D. et al. | 2001
- 77
-
PAR7: Validation of a Model of Severity of Illness in Chronic Respiratory DiseaseSullivan, P. / Nichol, M. et al. | 2001
- 77
-
PAR6: Prophylactic Medication Utilization and Health Care Costs in Older Adults with Chronic Pulmonary AilmentsBalkrishnan, R. / Christensen, D. / Bowton, D. et al. | 2001
- 78
-
PAR11: The Long-Term Societal Economic and Humanistic Benefits of Treating Acute Exacerbations of Chronic Bronchitis (AECB) with Gemifloxacin Versus ClarithromycinHalpern, M. / Kirsch, J. M. / Palmer, C. / Zodet, M. / Wilson, R. et al. | 2001
- 78
-
PAR9: Validation of a Rating Instrument Assessing the Inhalation Skills of Children with AsthmaPradel, F. G. / Weiss, S. / Tsoukleris, M. / Bollinger, M. B. / Fahlman, C. et al. | 2001
- 78
-
PAR10: Implementing Rasch Analysis in Psychometric Evaluation of Patient-Physician Interaction ScaleDalal, M. / Smith, E. / Lambert, B. / Olopade, C. / Crawford, S. et al. | 2001
- 79
-
PAR12: Prospective Use of Web Based Technology to Evaluate Health Outcomes in a Large Cohort of Severe or Difficult to Treat AsthmaticsDolan, C. M. / Fisher, K. A. / Johnson, C. / Fraher, K. E. / Rothermich, E. A. / Fine, J. T. / Weiss, S. T. / Wenzel, S. et al. | 2001
- 79
-
PAR13: Hypothetical Versus Real Willingness to Pay in the Health Care Sector: Results from a Field ExperimentBlumenschein, K. / Johannesson, M. / Yokoyama, K. / Freeman, P. et al. | 2001
- 80
-
PAR14: Assessment of the Relationship Between Disease Severity, Quality of Life and Willingness to Pay in AsthmaZillich, A. / Blumenschein, K. / Johannesson, M. / Freeman, P. et al. | 2001
- 80
-
PAR15: Comparison of Health Care Resource Utilization of COPD Patients on Cilomilast, 15 mg BID Versus PlaceboBagchi, I. / Bakst, A. / Edelson, J. / Amit, O. et al. | 2001
- 80
-
PAR16: Cost of Treating Asthma in a Managed Care PopulationArmstrong, E. P. / Malone, D. C. / Rehfeld, R. A. et al. | 2001
- 81
-
PAR17: Patient Satisfaction with Non-Sedating AntihistaminesSahu, S. / Millard, R. et al. | 2001
- 81
-
PAR19: Impact of the Addition of Salmeterol to the Treatment of Asthma Patients in a Medicaid Fee-for-Service PopulationKlaurens, L. M. / Dodd, M. A. / Gupchup, G. V. / Kelly, H. W. / Hollarbush, J. et al. | 2001
- 81
-
PAR18: Costs of Treating COPD in Italy: A Burden of Illness StudyBonzanini, A. / Avossa, R. / Scipioni, E. / Gianfrate, F. et al. | 2001
- 82
-
PAR20: Effectiveness of Compliance on Health Care Resource Use in Asthma Patients Treated with Montelukast vs. Inhaled CorticosteroidsKutikova, L. / Bowman, L. / Morris, L. et al. | 2001
- 82
-
PAR21: Levalbuterol Use is Associated with Decreased Health Care Costs in Patients with More Severe AsthmaHuse, D. / McLoney, A. / Yeager, B. / Cerasoli, F. et al. | 2001
- 83
-
PAR22: Impact of Levalbuterol Versus Racemic Albuterol on Outpatient Asthma Care ChargesHuse, D. / McLoney, A. / Yeager, B. / Cerasoli, F. et al. | 2001
- 83
-
PAR23: Determinants of Inappropriate Antibiotic PrescribingWillis, M. K. et al. | 2001
- 84
-
PCN1: Categorization of Risk of Prostate Cancer: Pilot Test of Clinical Outcomes and Risk PerceptionsBruner, D. W. / Parlanti, A. A. / Ross, E. / Raysor, S. / Mazzoni, S. E. / Hanks, G. E. et al. | 2001
- 84
-
PCN3: Predictors of Chemotherapy-Related Neutropenia: A Review of the Clinical LiteraturePalmer, C. / Brown, R. / Wilson-Royalty, M. / Lawless, G. et al. | 2001
- 84
-
PCN2: Which Variables Do Metastatic Breast Cancer Patients and Oncology Nurses Anchor on When Using the EuroQoL Descriptive System in Measuring Utilities with the Standard Gamble Technique?Hauser, R. / Koeller, J. et al. | 2001
- 85
-
PCN4: Comparing Mean Versus Median Survival as a Prelude to Cost-Effectiveness (C/E) AnalysesGagnon, D. D. / Martin, S. C. / van Hout, B. et al. | 2001
- 85
-
PCN5: Docetaxel/Doxorrubicin (DD) as First Line Chemotherapy: Quality of Life (QoL) in Patients (Pts) with Metastatic Breast Cancer (MBC)Bonicatto, S. C. et al. | 2001
- 86
-
PCN8: Economic Evaluation of Gemzar in the Treatment of Pancreatic Cancer in the UKStephenson, D. / Botwood, N. / McKendrick, J. / Aristides, M. / Lees, M. / Maniadakis, N. / Wein, W. et al. | 2001
- 86
-
PCN6: Can ICD-9 Codes Be Used as a Proxy for Disease Staging in Economic Evaluations?Thomas, S. K. / Brooks, S. E. / Mullins, C. D. et al. | 2001
- 86
-
PCN7: Economic Evaluation of Gemzar and Best Supportive Care (BSC) Relative to Best Supportive Care Alone in the Treatment of Non Small Cell Lung (NSCLC) Cancer in the UKMcKendrick, J. / Botwood, N. / Aristides, M. / Lees, M. / Maniadakis, N. / Wein, W. / Stephenson, D. et al. | 2001
- 87
-
PCN9: Economic Evaluation of Gemzar/Cisplatin Relative to Other New Agents for Non Small Cell Lung Cancer (NSCLC) in the UKLees, M. / Aristides, M. / Botwood, N. / McKendrick, J. / Maniadakis, N. / Wein, W. / Stephenson, D. et al. | 2001
- 87
-
PCN10: Cost-Effectiveness Model of Prostate-Specific Antigen (PSA) Screening for Prostate CancerSokolskiy, L. / Hay, J. W. et al. | 2001
- 88
-
PCN11: Economic Evaluation of Liposomal Doxorubicin vs Topotecan for Recurrent Ovarian Cancer in the UKSmith, D. H. / Drummond, M. F. / Johnston, S. / Gordon, A. et al. | 2001
- 88
-
PCN12: Cost-Utility Analysis Comparing Paclitaxel to Docetaxel in the Treatment of Metastatic Breast CancerHauser, R. / Theriault, R. / Shepherd, M. / Lawson, K. / Wilson, J. / Koeller, J. et al. | 2001
- 88
-
PCN13: Cost of Thrombocytopenia-Related Bleeding Among Patients with CancerElting, L. S. / Martin, C. G. / Hamblin, L. / Chau, Q. et al. | 2001
- 89
-
PCN14: Choice of Localized Breast Cancer Treatments in a Medicare Population: A Comparison of Outcomes and CostsPolsky, D. / Venditti, L. / Mandelblatt, J. S. / Weeks, J. C. / Hadley, J. / Hwang, Y. T. / Schulman, K. et al. | 2001
- 89
-
PCN15: Differences Between Preferences for Health States: The Chemotherapy Adverse Event Self-Assessed Response (CAESAR) QuestionnairePurdum, A. G. / Globe, D. / Mathes, A. / Nichol, M. B. et al. | 2001
- 90
-
PCN16: Chemotherapy Treatment in Newly Diagnosed Breast Cancer Patients in a Managed Care PopulationYazdani, C. / McLaughlin, T. / Koos, F. / Hansen, J. et al. | 2001
- 90
-
PCN17: An Analysis of Resource Use in the Treatment of Advanced Colorectal Cancer in the UKSorensen, S. / Brown, R. / De Cock, E. / Bearne, A. et al. | 2001
- 91
-
PCN20: Cost Minimization Analysis of Cefepime Versus Imipenem-Cilastatine in Cancer Patients with Short-Duration Febrile NeutropeniaVorobjov, P. / Fisenko, V. / Gerasimov, V. / Avxentieva, M. et al. | 2001
- 91
-
PCN18: Colorectal Cancer Screening: Awareness, Utilization, and BarriersStraus, W. / Schaffner, P. / Gold, K. / Pashos, C. / Mansley, E. et al. | 2001
- 91
-
PCN19: Colorectal Cancer Screening Tests: Variation in Preferences Based on Gender and RaceStraus, W. / Schaffner, P. / Gold, K. / Pashos, C. / Mansley, E. et al. | 2001
- 92
-
PCN21: Health-Related Quality of Life After Androgen Deprivation Therapy in Men with Prostate CancerLubeck, D. P. / Grossfeld, G. D. / Carroll, P. R. et al. | 2001
- 92
-
PCN22: Cost-Effectiveness Analysis Comparing Paclitaxel to Docetaxel in the Treatment of Metastatic Breast CancerHauser, R. / Koeller, J. et al. | 2001
- 93
-
PCN23: Disease Modeling: Developing the Infrastructure for a Comprehensive, Multi-National, Clinical and Economic Breast Cancer Treatment ModelBecker, R. V. / Noe, L. / Gore, M. / Martino, S. / Eiermann, W. / Namer, M. / Howell, A. / Bianco, A. / Watanabe, T. et al. | 2001
- 93
-
PCN24: Incidence and Cost of Hospitalization for 5-FU Toxicity Among Medicare Beneficiaries with Metastatic Colorectal CancerDelea, T. E. / Vera-Llonch, M. / Edelsberg, J. S. / McGarry, L. / Anton, S. / Ulcickas-Yood, M. / Oster, G. et al. | 2001
- 93
-
PCN25: A Quality of Life Audit of Patients with Non-Small Cell Lung Cancer Having Chemotherapy at One InstitutionMusgrave, K. R. / Wyld, D. / Abraham, R. et al. | 2001
- 94
-
PCN27: Cost of Treatment for Squamous Cell Carcinoma of the Head and Neck in the United StatesCronin, K. / Lee, B. / Wang, D. et al. | 2001
- 94
-
PCN26: Systematic Assessment of Health-Related Quality of Life Instruments for Use in Clinical Trials of Non-Small Cell Lung CancerHuang, J. C. / Veenstra, D. L. et al. | 2001
- 95
-
PCN28: Detecting Recurrent Papillary or Follicular Thyroid Cancer in Clinical Practice: Need for a Change?Hooft, L. / Hoekstra, O. S. et al. | 2001
- 95
-
PCV2: Venous Thromboembolic (VTE) Complications Following Major Orthopedic Surgery: Frequency and Economic Consequences in HospitalGabriel, S. / Dinet, J. / Dispot, T. / Radal, C. et al. | 2001
- 95
-
PCV1: A Cost-Effectiveness Analysis of Clopidogrel Versus Aspirin as Prevention of Ischemic Events in Patients with Established Peripheral Artery DiseaseDecerbo, M. C. / Baroletti, S. A. / Isopo, S. / Silva, M. / Talati, D. K. et al. | 2001
- 96
-
PCV4: Assessing Quality of Life in Patients Six Months After a Myocardial Infarction Using the SF-12McBurney, C. R. / Erickson, S. R. / Kline-Rogers, E. M. / Cooper, J. V. / Mani, O. C. / Eagle, K. A. et al. | 2001
- 96
-
PCV3: An Analysis of the Cost of Adverse Events Associated with the Use of HMG-CoA Reductase InhibitorsMcBurney, C. R. / Smith, D. et al. | 2001
- 97
-
PCV7: Cost-Utility Analysis of Drug Therapy Options for Intermittent ClaudicationMcGhan, W. F. et al. | 2001
- 97
-
PCV5: Cost of Treatment and Prevalence of Cardiovascular Disease Comorbidities and Risk Factors in the Severe and Persistently Mentally IllBellnier, T. J. / Labrum, A. / Karki, S. D. / Sundberg, J. et al. | 2001
- 97
-
PCV6: Estimating Incremental Costs for Additional Hospital DaysFriedman, J. Y. / Reed, S. D. / Gnanasakthy, A. / Schulman, K. A. et al. | 2001
- 98
-
PCV9: An Economic Analysis of Congestive Heart Failure (CHF) in the Louisiana Medicaid ProgramOgale, S. S. / Blake, S. G. / Biglane, G. C. / Medon, P. J. et al. | 2001
- 98
-
PCV10: Incidence of Rhabdomyolysis in Patients Initiated on HMG Co-A Reductase Inhibitor Therapy in a Managed Care OrganizationWhite, T. J. / Chang, E. Y. et al. | 2001
- 98
-
PCV8: Patient Compliance with Different Prescribed Regimens of Diltiazem in Angina Pectoris: Database Analysis in FranceBaptiste, C. / Guilhaume, C. et al. | 2001
- 99
-
PCV12: Quality of Care in Older Patients Admitted to Hospital with Heart FailureAbdelhafiz, A. H. / Wheeldon, N. et al. | 2001
- 99
-
PCV11: Cost of Warfarin Treatment of Atrial Fibrillation in Clinical PracticeAbdelhafiz, A. H. / Wheeldon, N. et al. | 2001
- 100
-
PCV13: Impact on Quality Adjusted Life Years on Enoxaparin for Preventing Thrombosis Among Hospitalized Medical PatientsRaisch, D. W. / Fye, C. L. / Sather, M. R. / Henderson, W. G. / Reda, D. J. / Sacks, J. M. / Lederle, F. L. et al. | 2001
- 100
-
PCV15: Economic Evaluation of Outpatient Anticoagulant/Antiplatelet Therapy Following Coronary Stenting in a Managed Care PopulationLiao, E. / Fronk, M. / Newell, J. / Huse, D. et al. | 2001
- 100
-
PCV14: Impact of Obesity on Health-Related Quality of Life (HRQoL): An Analysis of Behavioral Risk Factor Surveillance System (BRFSS) DataHassan, M. / Joshi, A. V. / Madhavan, S. / Amonkar, M. et al. | 2001
- 101
-
PCV16: Cost-Effectiveness Analysis of Enoxaparin Versus Unfractionated Heparin in Acute Coronary Syndrome Patients in PolandOrlewska, E. / Budaj, A. / Tereszkowski-Kaminski, D. et al. | 2001
- 101
-
PCV17: Quality of Life and Patient Preference as Predictors for Resource Utilization Among Patients with Heart Failure; Interim AnalysisShin, G. P. / Tooley, J. F. / Southworth, M. R. / Dunlap, S. / Boyer, J. G. / Johnson, N. E. et al. | 2001
- 102
-
PCV20: Assessing the Total Cost of Management of a Patient with Deep Vein Thrombosis (DVT) in France and in ItalyLevy, E. / Gabriel, S. / Dinet, J. / Rudelli, G. et al. | 2001
- 102
-
PCV19: Discriminability for Risk of Cardiovascular EventsMilne, R. J. / Gamble, G. D. / Whitlock, G. / Irwin, R. J. / Jackson, R. T. et al. | 2001
- 102
-
PCV18: Framingham Risk Equations Predict Hospital Usage and MortalityMilne, R. J. / Gamble, G. D. / Whitlock, G. / Jackson, R. T. et al. | 2001
- 103
-
PCV22: In-Patient and Out-Patient Resource Utilization Among Patients with Acute Ischemic Stroke-The VA ExperienceL Italien, G. J. / Williams, L. S. / Weinberger, M. et al. | 2001
- 103
-
PCV21: Cost-Effectiveness Analysis of Abciximab, Eptifibatide, and Tirofiban in Patients with Coronary SyndromesShahriar, J. / Shaw, J. W. / Malone, D. et al. | 2001
- 104
-
PCV24: Beyond the First Year: Patterns and Predictors of Long-Term Statin UtilizationBenner, J. S. / Federman, A. D. / Smitten, A. L. / Duty, S. / Glynn, R. J. / Avorn, J. et al. | 2001
- 104
-
PCV23: Pharmacoeconomic Evaluation of Usage of Unfractionated Heparin and Low Molecular Weight Heparin in the Treatment of Deep Vein Thrombosis in Long-Term Care ResidentsKarki, S. D. / Bellnier, T. J. / Karki, J. / Patterson, W. / Masood, R. et al. | 2001
- 104
-
PCV25: CHD Risk Factors and Therapy Duration of HMG-CoA Reductase Inhibitors (Statins) in a Medicaid PopulationNichol, M. B. / Bron, M. S. / Yu, W. et al. | 2001
- 105
-
PCV26: Caring for Hypertension on Initiation: Costs and Effectiveness (CHOICE). Design and Rationale of a Naturalistic StudyPayne, K. / Caro, J. / Hollenberg, N. / Jackson, J. / L Italien, G. / CHOICE Study Group et al. | 2001
- 105
-
PCV27: A Pharmacoeconomic Model to Evaluate Treatment Options for DVT PharmacoprophylaxisSpruill, W. J. / Wade, W. E. / Leslie, R. B. et al. | 2001
- 105
-
PCV28: Cholesterol Reduction Success Rates and Resource Utilization by GenderGraff, J. S. / Plante, M. / Smith, D. et al. | 2001
- 106
-
PCV30: Cost-Effectiveness Model of Thrombolytic Therapy for Acute Myocardial InfarctionMulani, P. / Hay, J. et al. | 2001
- 106
-
PCV29: Economic Outcomes of Patients Receiving Carvedilol Compared to Those Receiving No Beta-Blocker Therapy for the Treatment of Congestive Heart Failure in a Managed Care OrganizationWhite, T. J. / Chang, E. Y. / Leslie, R. S. / Jackson, A. J. et al. | 2001
- 107
-
PCV31: Closure of Atrial Septal Defect: Medico-Economic Arguments to Choose Between Invasive Surgery and Percutaneous Technique Using Septal OccluderLaroche, S. / Allenet, B. / Foroni, L. / Calop, J. et al. | 2001
- 107
-
PCV32: Strategies for Improving Compliance with HMG-CoA Reductase InhibitorsCoombs, J. H. / Cornish, L. / Hiller, P. / Smith, D. G. et al. | 2001
- 107
-
PCV33: Cost-Analysis of CABG Surgery in Patients with and without Rethoracotomy from the Hospital Perspective in GermanySpannheimer, A. / Mast, O. / Schlereth, T. / Thate-Waschke, I. M. / Dietrich, W. et al. | 2001
- 108
-
PCV34: Decision Analysis Model of Abciximab, Eptifibatide or Standard Therapy in Elective Stent Placement: A Canadian PerspectiveSridhar, K. / Gwadry, F. / Kidwai, B. / Almond, D. / Teefy, P. et al. | 2001
- 108
-
PCV35: Comparability of Published Studies on Cost-Effectiveness of Antihypertensive Therapy: Do the Results Help the Decision-Making Process?Mullins, C. D. / Akhras, K. S. / Blak, B. et al. | 2001
- 109
-
PCV37: The Cost-Effectiveness of Statins: Evidence from the ACCESS TrialSmith, D. G. et al. | 2001
- 109
-
PCV36: Evaluation of Compliance and Persistence with HMG-CoA Reductase Inhibitors After a Myocardial Infarction Using Pharmacy Claims DataCoombs, J. H. / Cornish, L. / Hiller, P. / Smith, D. G. et al. | 2001
- 110
-
PCV40: Cost-Effectiveness of Lipid Lowering Interventions in a Native American Cardiovascular Risk Reduction ProgramKumar, R. N. / Borrego, M. E. / Gupchup, G. V. / Anderson, J. R. / Burden, R. W. / Phillips, D. L. et al. | 2001
- 110
-
PCV38: Withdrawn| 2001
- 110
-
PCV39: Cost of Treatment of Hypercholesterolaemia to NHF Goals in AustraliaWlodarczyk, J. / Barter, P. j. / O Brien, R. / Talmont, D. / Ortiz, M. et al. | 2001
- 111
-
PCV41: Socioeconomic Relevance of Treatment of Chronic Heart Failure Stage NYHA II With Crataegus Extract WS 1442-One-Year Results of a Prospective Pharmacoeconomic StudyPfeil, T. / Rychlik, R. / Daniel, D. / Habs, M. / Klapper, H. G. / Bohm, M. et al. | 2001
- 111
-
PCV42: Patients' Willingness to Pay for Pharmacist Managed Warfarin Therapy at Community PharmaciesWong, P. K. / Jang, R. et al. | 2001
- 112
-
PDB1: Diabetic Management Through Oral Glucose Lowering Agents: Treatment Pattern, Cost and Utilization AnalysisThompson, F. D. / Rosenblum, M. S. / O Neill, J. M. / Celebi, D. / Olmsted, E. et al. | 2001
- 112
-
PDB2: Using Retrospective Claims Data to Design Clinical Safety Surveillance of Thiazolidinedione DrugsHenriques, C. / Schultz, D. / Milanette, T. / Todoroff, K. / Kim, M. et al. | 2001
- 113
-
PDB3: The Burden of Illness of Diabetes Mellitus Type 2 in Germany-A Pilot StudyTepe, M. / Kilburg, A. / Daniel, D. / Kirchhoff, D. / Rychlik, R. et al. | 2001
- 113
-
PDB4: Cost-Effectiveness and Cardiovascular Risk-An Analysis of Rosiglitazone Compared with other Oral Hypoglycemic Agents in the Treatment of Type 2 Diabetes MellitusOh, P. I. / Shane, L. G. et al. | 2001
- 114
-
PDB7: Costs and Effectiveness of Intensive Insulin Therapy for Type 2 DiabetesHisashige, A. / Katayama, T. / Mikasa, H. et al. | 2001
- 114
-
PDB5: A Cost-Minimization Study to Determine the Impact of Adding Glucovance to a County Hospital FormularyLal, L. S. / Ogbonnaya, K. I. et al. | 2001
- 114
-
PDB6: An Early Look at TZD Use Among Type 2 Diabetes PatientsSchabert, V. F. / Guo, M. / Conklin, J. E. / Neslusan, C. A. et al. | 2001
- 115
-
PDB8: Factors Associated with Prescription Claims for Blood Glucose Test Strips Among Fee-for-Service New Mexico Medicaid PatientsCordova, C. J. / Shah, B. M. / Dodd, M. A. / Gupchup, G. V. et al. | 2001
- 115
-
PDB10: The Cost of New Onset Diabetes Mellitus Among US Renal Transplant RecipientsWoodward, R. S. / Schnitzler, M. A. / Lowell, J. A. / Haider, S. / Brennan, D. C. et al. | 2001
- 115
-
PDB9: Cost-Effectiveness Analysis of a Multidisciplinary Diabetes Care ClinicYokoyama, K. K. / Griffin, K. C. / Godley, P. J. / Cryar, A. K. / Woodward, B. W. et al. | 2001
- 116
-
PDB13: Optimization of Diabetes Management in Germany Using a Computer Based Outcome Prognoses ModelBrandt, A. / Gozzoli, V. / Palmer, A. / Weiss, C. / Neeser, K. / Schramm, W. et al. | 2001
- 116
-
PDB11: Economic Outcomes of Diabetes Among an Employed PopulationLeong, S. A. / Summers, K. H. / Birnbaum, H. G. / Kemner, J. E. / Lentz, E. C. / Greenberg, P. E. et al. | 2001
- 116
-
PDB12: A Pharmacoeconomic Analysis of Weight-Reduction Therapy in a Hypothetical Cohort of Obese Chinese Patients with Impaired Glucose ToleranceLee, K. K. / You, J. H. / Ho, S. S. / Leung, W. Y. / Thomas, G. / Chan, T. Y. / Critchley, J. et al. | 2001
- 117
-
PDB14: Impact of a Diabetes Disease Management Program: A Retrospective Claims-Based EvaluationBerger, J. / Slezak, J. / O Leary, W. / McStay, P. / Johnson, K. / Addiego, J. et al. | 2001
- 117
-
PDB15: Does Patient Experience Matter? Type II Diabetes Patients' Stated Preferences for Insulin TherapiesSmith, G. / Bingham, M. / Johnson, F. R. / Bolinder, B. et al. | 2001
- 118
-
PEE2: The Cost-Effectiveness of Genetic Testing for Periodontal Disease. A Payer's PerspectiveHigashi, M. K. / Veenstra, D. / del Aguila, M. / Hujoel, P. et al. | 2001
- 118
-
PEE1: Antibiotic Prescribing Patterns for the Treatment of Initial Acute Otitis Media in Children Enrolled in Iowa Medicaid from 1990 Through 1997Park, T. R. / Brooks, J. M. et al. | 2001
- 118
-
PDB16: An Overview of Pharmacoeconomics in Turkey: Cost Analysis and Reimbursement of Antidiabetic DrugsSapci, A. H. / Sapci, H. A. / Demirdamar, R. et al. | 2001
- 119
-
PEE4: The French Version of the Psoriasis Disability IndexFinlay, A. / Corvest, M. / Lefrancois, P. / Taieb, C. et al. | 2001
- 119
-
PEE5: Inappropriate Antibiotic Prescribing and Economic Outcomes for Pediatric Otitis MediaRahman, A. M. / Feldhaus, J. / Lawrence, L. / Rappaport, H. / Moser, E. et al. | 2001
- 119
-
PEE3: Dry-Eye Related Increases in Health Care Utilization and ExpendituresSmeeding, J. E. / McLaughlin, T. / Yazdani, C. / Walt, J. G. et al. | 2001
- 120
-
PEE6: Cost-Effectiveness of Artificial Skin Substitute vs Allograft for Burn PatientsBron, M. S. / Hay, J. et al. | 2001
- 120
-
PEE7: A Cost Comparison Study of Common Practice and Best Practice Treatment for Primary Open-Angle Glaucoma in the United StatesEvans, S. J. / Casciano, J. / Doyle, J. J. / Walt, J. G. et al. | 2001
- 121
-
PGI2: Alternative Management Strategies for DyspepsiaWu, E. Q. / Hay, J. et al. | 2001
- 121
-
PGI1: Effects on Health Care Contacts and Days Absent from Work with Budesonide CIR Capsules in the Maintenance Treatment of Crohn's Disease in a US SettingEricsson, K. / Borg, S. et al. | 2001
- 121
-
PEE8: Four Year Cost-Effectiveness of Initial Trabeculectomy Versus Conventional Therapy in Primary Open-Angle Glaucoma (POAG)Yu, E. / Hay, J. / Varma, R. / Globe, D. et al. | 2001
- 122
-
PGI3: A Prospective, Randomized Cost Analysis of Meperidine and Midazolam Versus Propofol for Complex Upper Endoscopy ProceduresShermock, K. M. / Vargo, J. J. / Zuccaro, G. / Maurer, W. G. et al. | 2001
- 122
-
PGI4: Health-Related Quality of Life (HRQoL) Data Reveal Differences Among Clinical "Responders"Watson, M. E. / Heath, A. T. / Northcutt, A. R. et al. | 2001
- 123
-
PGI6: Cost-Effectiveness Analysis of Helicobacter pylori Eradication Triple Therapy Versus Conventional Therapy for Gastric and Duodenal Ulcers in JapanIkeda, S. / Tamamuro, T. / Asaka, M. et al. | 2001
- 123
-
PGI7: Budesonide CIR is Cost-Effective in Maintenance Therapy of Crohn's Disease in FinlandEricsson, K. / Karvonen, A. L. / Sintonen, H. / Borg, S. et al. | 2001
- 123
-
PGI5: Health Care Cost Savings with Budesonide Controlled Ileal Release Capsules (CIR) in Crohn's DiseaseEricsson, K. / Lofberg, R. / Danielsson, A. / Floren, C. H. / Borg, S. et al. | 2001
- 124
-
PGI9: Cost-Effectiveness of `Test&Treat' in Helicobacter pylori Infected Dyspeptic Patients in a Primary Care SettingChen, K. S. / Hay, J. et al. | 2001
- 124
-
PGI8: Rapid Impact of Rabeprazole on Symptom Distress Among Patients with Gastroesophageal Reflux DiseaseDamiano, A. / Adler, E. / Siddique, R. / Sloan, S. / Bhattacharjya, A. et al. | 2001
- 125
-
PGI10: Irritable Bowel Syndrome Costs Sickness Funds DM 2.8 Billion Per YearSchultes, H. J. / Guminski, W. / Rosche, U. / Ries, B. / Pirk, O. et al. | 2001
- 125
-
PGI11: Characterization and Markov Modeling of Gastroesophageal Reflux Disease States in a Large Health Care PlanBrelje, T. / Heaton, A. / Martin, S. / Bhattacharjya, A. / Dodd, S. / Thornhill, J. et al. | 2001
- 125
-
PGI12: Estimating Potential Utilization of Esomeprazole by Assessing GERD Symptom Control on Traditional PPI'sDeLattre, M. L. / Schaefer, M. / Morreale, A. P. / Plowman, B. K. et al. | 2001
- 126
-
PGI14: How Important is Appropriate Empirical Antibiotic Treatment for Intra-Abdominal Infections?Davey, P. / Libby, G. / Hunter, K. / Broomhall, J. / Kofteridis, D. / Steinke, D. / Taylor, E. / Yin, D. et al. | 2001
- 126
-
PGI13: Factors Associated with Physician Knowledge of Whether Prescription Drugs Are on FormularyShih, Y. C. / Sleath, B. et al. | 2001
- 127
-
PGI17: Comparison of Generic Versus Disease Specific Tools for the Measurement of Health-Related Quality of Life in Crohn's DiseaseWurtzbacher, J. D. / Gourley, G. K. / Reed, P. J. / Gourley, D. R. / Solomon, D. K. / Haas, J. W. et al. | 2001
- 127
-
PGI15: Computerized Assessment of Complications Following Colorectal SurgeryKroch, E. / Azimuddin, K. / Rosen, L. / Reed, J. F. et al. | 2001
- 127
-
PGI16: Analysis of the Long-Term Costs, Savings and Effects Generated by Infliximab to Normalize Quality of Life in Patients with Crohn's DiseaseAnnemans, L. / Moeremans, K. / Rutgeerts, P. / Lemmens, L. et al. | 2001
- 128
-
PID2: Impact of Cytomegalovirus (CMV)-Related Readmission on Post Heart Transplant Resource UseLeader, S. / Henderson, R. / Carlin, D. et al. | 2001
- 128
-
PID1: Efficacy of Zinc Lozenges on the Duration of Common Cold Symptoms: A Meta-Analysis RevisitedChaiyakunapruk, N. / Veenstra, D. L. / Sullivan, S. D. / Saint, S. / Bent, S. et al. | 2001
- 129
-
PID4: Economic Cost of HIV Infection in Untreated Workers: An Employer's PerspectiveChaikledkaew, U. / Liu, G. G. / Lyu, R. / Louie, S. et al. | 2001
- 129
-
PID3: Trends in Inpatient Costs for Acute Pancreatitis in the United StatesBell, C. F. / Stephens, J. M. / Botteman, M. F. / Pashos, C. L. / Ewing, M. et al. | 2001
- 129
-
PID5: Moxifloxacin vs Amoxicillin/Clavulanate in the Treatment of Acute Maxillary Sinusitis (AMS): Efficacy, Safety and Patient-Reported Outcomes in Primary CareRakkar, S. et al. | 2001
- 130
-
PID6: HIV/AIDS Health State Utilities Using Community and Patient Preference Weights: When Does It Matter?Schackman, B. R. / Goldie, S. J. / Freedberg, K. A. / Losina, E. / Brazier, J. / Weinstein, M. C. et al. | 2001
- 130
-
PID7: Observational Evaluation of Health State Utilities Among a Cohort of Sepsis PatientsDrabinski, A. / Williams, G. / Formica, C. et al. | 2001
- 131
-
PID8: Costs of Health Care for Hepatitis C-Infected Members in a Managed Care Organization (MCO)Schaffer, M. / Phillips, A. L. / Mansukani, S. et al. | 2001
- 131
-
PID10: Effects of Linezolid on Hospital Length of Stay in Methicillin-Resistant Staphylococcus Infections Estimated from Multivariate Survival AnalysisWillke, R. J. / Li, Z. J. / Glick, H. / Rittenhouse, B. E. / Hafkin, B. et al. | 2001
- 131
-
PID9: Cost-Effectiveness of Interferon Alfa Therapy for Chronic Hepatitis C with CirrhosisHisashige, A. / Katayama, T. / Mikasa, H. et al. | 2001
- 132
-
PID12: Averting Future AIDS Cases: Modeling Costs of Interventions with Out-of-Treatment Substance AbusersRichter, A. / Loomis, B. R. / Wechsberg, W. M. et al. | 2001
- 132
-
PID11: Pegylated (40KDa) Interferon Alfa-2a (PEGASYS®) Significantly Improves Tolerability, Quality of Life, and Work Productivity in Patients With Chronic Hepatitis CImperial, J. / Thuluvath, P. / Perrillo, R. P. / Rothstein, K. D. / Poulios, N. S. / Pappas, S. C. / Ackermann, S. P. / Doerschuk, B. S. et al. | 2001
- 133
-
PID14: Predictors of the Mental (MHS) and Physical Health Summary (PHS) Scores of the MOS-HIV in a Sample of HIV-Infected PatientsGriffis, D. L. / Delate, T. / Coons, S. J. et al. | 2001
- 133
-
PID13: Economic Evaluation of Rotavirus Vaccination for The NetherlandsWelte, R. / Jager, J. / van Duynhoven, Y. / de Wit, M. et al. | 2001
- 133
-
PID15: Managing AIDS in the Era of Antiretroviral Therapy: Changes in the Rate and Cost of HospitalizationsO Brien, J. A. / Pierce, D. / Patrick, A. R. / Caro, J. J. et al. | 2001
- 134
-
PID18: Methicillin-Resistant Staphylococcus Species Treatment Patterns in CanadaBecker, D. / Rosner, A. J. et al. | 2001
- 134
-
PID16: Cost Burden of Varicella-Zoster Virus Infection in a Managed Care SettingSchaffer, M. / Liu, M. / Scott, W. / Mansukani, S. et al. | 2001
- 134
-
PID17: Economic Evaluation of Oseltamivir for Influenza Patients in JapanKobayashi, M. et al. | 2001
- 135
-
PID19: An Economic Analysis of Cefdinir Versus Loracarbef for Treatment of Acute Exacerbations of Chronic BronchitisShah, S. N. / Smith, D. / Copley-Merriman, C. et al. | 2001
- 135
-
PID20: Targeting Populations At-Risk for Urinary Tract Infection ComplicationDoyle, B. / Hess, G. et al. | 2001
- 136
-
PID23: Patterns of Antibiotic Use and Costs Associated with Episodes of Treatment for Common Outpatient Respiratory-Tract Infections: An Analysis of Managed-Care DataEdelman-Lewis, B. / Menzin, J. / Boulanger, L. / Leung, M. / Friedman, M. / Hurley, J. S. / Harnett, J. / Wilson, J. et al. | 2001
- 136
-
PID22: An Appraisal of Health-Related Quality of Life Instruments for Use in Patients Diagnosed with Human Immunodeficiency Virus (HIV) DiseaseJoshi, A. V. / Nau, D. P. / Kalsekar, I. D. et al. | 2001
- 136
-
PID21: The Cost-Effectiveness Analysis of Lamivudine in the Treatment of Chronic Hepatitis B in PolandOrlewska, E. et al. | 2001
- 137
-
PID25: Economic Evaluation of Macrolides and Fluoroquinolones for the Treatment of Respiratory Tract InfectionsLachaine, J. / Laurier, C. / Manzi, P. et al. | 2001
- 137
-
PID24: Cost Comparison of Gatifloxacin Versus Levofloxacin in the Treatment of Community-Acquired Pneumonia in an Outpatient PopulationBell, T. J. / Loomis, B. R. / Mauskopf, J. A. / L Italien, G. J. / Gallagher, K. M. et al. | 2001
- 138
-
PID27: Does a Day Still Make a Difference? A Decision Analysis of Adult Streptococcal PharyngitisRousculp, M. D. et al. | 2001
- 138
-
PID26: Pharmacoeconomic Evaluation of Cefuroxime in Abdominal HysterectomyKarpov, O. / Zaytsev, A. et al. | 2001
- 138
-
PID28: Comparing Differences in Clinical Effectiveness, Nephrotoxicity, and Cost-Effectiveness of Aminoglycoside Therapy Between Alternative Dosing ProtocolsReynolds, R. / Gupchup, G. / Borrego, M. / Raisch, D. / Netravali, S. et al. | 2001
- 139
-
PMH2: Treatment Course and Charges for Depressed Patients Treated with Sertraline, Venlafaxine, and Venlafaxine XR in the Managed Care SettingHirschfeld, R. / Eaddy, M. / Grudzinski, A. et al. | 2001
- 139
-
PMH1: Should the 51 Items of the Schizophrenia Outcomes Assessment Project (SOAP-51) Be Weighted?Barr, J. / Schumacher, G. / Mason, E. / Ohman, S. / Goren, J. / Hanson, A. et al. | 2001
- 140
-
PMH3: Is Depression the Major Cause of Impaired Quality of Life in Schizophrenic Patients?Toumi, M. / Pettersson, A. / Llorca, P. M. / Lancon, C. / Aballea, S. et al. | 2001
- 140
-
PMH4: Assessment of Patients' Attitudes Toward Antipsychotic Treatment in a 40-Week Randomized, Controlled TrialDugar, A. / Stuelpner, J. E. / Mackell, J. A. / Miceli, R. J. et al. | 2001
- 140
-
PMH5: From First to Second: Impact of Participant Characteristics on the Time to First Switch in a Schizophrenia PopulationRusso, P. / Vasey, J. et al. | 2001
- 141
-
PMH6: Change in Instrumental Activities of Daily Living Associated with Antidepressants in Older Depressed PatientsEdell, W. S. / Mayo, K. W. / Bailey, K. L. / Sandoval, R. I. / Adams, B. E. / Jensik, S. E. et al. | 2001
- 141
-
PMH7: Change in Maladaptive Behaviors Associated with Antidepressants in Older Depressed PatientsJensik, S. E. / Mayo, K. W. / Bailey, K. L. / Sandoval, R. I. / Edell, W. S. / Adams, B. E. et al. | 2001
- 142
-
PMH9: Health Care Utilization and Costs in Schizophrenic Patients Taking Risperidone Versus Olanzapine in a Veterans Administration PopulationShermock, K. M. / Fuller, M. A. / Secic, M. / Laich, J. S. / Durkin, M. B. et al. | 2001
- 142
-
PMH10: Health Outcomes of Childhood Attention-Deficit/Hyperactivity Disorder (ADHD): Health Care Use and Work Status of CaregiversNoe, L. / Hankin, C. S. et al. | 2001
- 142
-
PMH8: Impact of Current Antidepressants on Cognition in Older Patients with DepressionAdams, B. E. / Mayo, K. W. / Sandoval, R. I. / Bailey, K. L. / Jensik, S. E. / Edell, W. S. et al. | 2001
- 143
-
PMH12: Prevalence of Comorbid Anxiety and Depression Among Patients Prescribed SSRI MonotherapyGrotzinger, K. M. / Chang, L. L. et al. | 2001
- 143
-
PMH11: Schizophrenia Care and Assessment Program (SCAP): The Impact of Clinical Syndrome, Antipsychotic Medication Treatment and Adherence on Outpatient Psychiatric UtilizationRusso, P. / Smith, M. et al. | 2001
- 144
-
PMH13: Pre-Treatment Patient Differences: Choice of Drug Therapy Within SchizophreniaGibson, P. J. / Loosbrock, D. L. et al. | 2001
- 144
-
PMH14: Deficit Syndrome and Drug Use Patterns in a Community-Based Schizophrenia CareRusso, P. / Kirkpatrick, B. et al. | 2001
- 144
-
PMH15: A Retrospective Economic Evaluation of Olanzapine Versus Risperidone in the Treatment of SchizophreniaZhao, Z. et al. | 2001
- 145
-
PMH16: Use of Rasch Models for Validation of Instruments Used in Mental Health EvaluationLancon, C. / Toumi, M. / Pettersson, A. / Aballea, S. / Fournier, A. et al. | 2001
- 145
-
PMH17: Typical and Atypical Antipsychotics in the Treatment of Schizophrenia: Assessment of Clinical And Economic Outcomes Using a Markov ModelNeeser, K. / Schramm, W. / Brandt, A. / Hoffler, J. / Jurgens, T. / Mast, O. et al. | 2001
- 146
-
PMH18: Health Care Utilization in Patients with Treatment Resistant DepressionCrown, W. H. / Ling, D. C. / Finkelstein, S. N. / Berndt, E. R. / White, A. S. et al. | 2001
- 146
-
PMH20: Dosing of Benzodiazepine Hypnotics in Elderly PatientsYoung, J. K. / Schultz, D. / Foster, D. / Heller, S. et al. | 2001
- 146
-
PMH19: Risk of Hospitalization for Patients with Bipolar DisorderLing, D. C. / Bresnahan, B. W. / White, A. S. / Neslusan, C. A. / Crown, W. H. et al. | 2001
- 147
-
PMH22: Patterns of Antidepressant Use and Health Care Costs in Depressed Patients Who Received SSRI TherapyWade, S. W. / Berzon, R. / Patton, M. P. / Koch, P. / Batra, D. et al. | 2001
- 147
-
PMH21: Quality of Life of Non-Institutional Caregivers of Schizophrenic Patients: Contribution of Qualitative Interviews to Questionnaire GenerationAuquier, P. / Simeoni, M. C. / Azorin, J. M. / Lancon, C. / Toumi, M. et al. | 2001
- 148
-
PMH24: The Cost of Acute Hospitalization for Anorexia Nervosa and BulimiaO Brien, J. A. / Patrick, A. R. et al. | 2001
- 148
-
PMH23: Deinstitutionalization of Schizophrenic Patients: Cost-Consequences and Policy Implication of Intensive Case Management Versus Standard Case ManagementLlorca, P. M. / Toumi, M. / Hansen, K. / Barre, S. / Francois, C. et al. | 2001
- 148
-
PMH25: A Model Comparing Olanzapine and Ziprasidone in Patients with SchizophreniaAlexeyeva, I. / Mauskopf, J. / Earnshaw, S. / Gibson, P. J. / Ascher-Svanum, H. / Ramsey, J. L. et al. | 2001
- 149
-
PMH26: Outpatient Antipsychotic Use: Comparing Atypical and Conventional Antipsychotic Adherence Using a National Retail Pharmacy Data BaseVanelli, M. R. et al. | 2001
- 149
-
PMH28: Depression and Homelessness, a French InitiativeEmmanuelli, X. / Hassin, J. / Smadja, C. / Taieb, C. et al. | 2001
- 149
-
PMH27: Cost-Utility Analysis of Quetiapine Compared to Risperidone in the Treatment of Patients with Schizophrenia or Other Psychotic DisordersSimons, W. R. / Meddis, D. et al. | 2001
- 150
-
PMH29: Cost Analysis of Olanzapine Versus Risperidone in the Treatment of Uncontrolled SchizophreniaZhao, Z. et al. | 2001
- 150
-
PMH30: Differences in Health Care Expenditures Among Patients Treated for Depression with or without AnxietyCrown, W. / Wan, G. J. / Berndt, E. R. / Finkelstein, S. N. / Ling, D. et al. | 2001
- 151
-
PMH31: Pharmacoeconomic Evaluation of the Treatment with Olanzapine in "Revolving Door" Schizophrenic PatientsGurovich, I. / Lyubov, E. / Shmukler, A. et al. | 2001
- 151
-
PMH33: Olanzapine Versus Risperidone in the Treatment of Schizophrenia: A Comparison of Costs Among Texas Medicaid PatientsRascati, K. L. / Johnsrud, M. / Crismon, M. L. / Barber, B. L. / Lage, M. J. et al. | 2001
- 151
-
PMH32: Barriers to the Use of Medications to Treat AlcoholismMark, T. L. / Kranzler, H. R. / Poole, V. H. / Hagen, C. A. / McLeod, C. / Crosse, S. E. et al. | 2001
- 152
-
PMH34: Switching and Augmentation of Antidepressants in Older Depressed PatientsAdams, B. E. / Jensik, S. E. / Mayo, K. W. / Bailey, K. L. / Sandoval, R. I. / Edell, W. S. et al. | 2001
- 152
-
PMH35: Patterns of Antidepressant and Antipsychotic Medication Use in Medicaid, 1995-1999Gregorian, R. / Gemmen, E. et al. | 2001
- 153
-
PPN1: An Internet Study of WTP for Migraine PharmacotherapiesLenert, L. A. / Minh, C. / Jackson, C. et al. | 2001
- 153
-
PMH36: Dosing of Benzodiazepine Hypnotics in Elderly PatientsYoung, J. K. / Schultz, D. / Foster, D. / Heller, S. et al. | 2001
- 153
-
PPN2: Use of Galantamine in The Netherlands for the Treatment of Mild to Moderate Alzheimer's DiseaseCard, J. / Salas, M. / Getsios, D. / Mehnert, A. / AHEAD Study Group et al. | 2001
- 154
-
PPN3: The Impact of Dementia on Caregiver Quality of LifeGold, K. F. / Botteman, M. F. / Kemp, R. / Kittner, B. / Pashos, C. L. et al. | 2001
- 154
-
PPN4: Utility Assessments of Opioid Treatment in the US, Canada and Australia for Patients with Chronic Non-Malignant PainSchmier, J. / Palmer, C. / Ingham, M. / Mathur, S. / Dodd, S. / Gourlay, G. et al. | 2001
- 155
-
PPN6: Validation of the 24 Hour Headache Disability Questionnaire (DISQ-24) in a Sample of Headache SufferersRunken, M. C. / Kwong, W. / Davis, K. / Batenhorst, A. et al. | 2001
- 155
-
PPN7: A Model for Predicting the Incidence of Migraine in the Idaho Medicaid PopulationShaw, J. / Joish, V. / Cady, P. S. et al. | 2001
- 155
-
PPN5: Comparison of Costs and Cost-Effectiveness of Oxcarbazepine and Sodium Valproate for New/Recent Onset Partial SeizuresBazalo, G. / Sachdeo, R. / Graham, S. / Chang, S. / Cohen, A. et al. | 2001
- 156
-
PPN8: Psychometric Evaluation of Widely Used Pain Measures for Purpose of Computerized Dynamic Pain AssessmentZhao, J. H. / Ware, J. E. / Kosinski, M. / Bjorner, J. B. / Turner-Bowker, D. et al. | 2001
- 156
-
PPN9: How is Pain Felt Across Countries? The Short-Form McGill Pain Questionnaire (SF-MPQ) in 10 LanguagesConway, K. / Uzun, V. / Alacoque, J. / Abetz, L. / Melzack, R. / Plante, M. et al. | 2001
- 157
-
PPN12: Differences in Health-Related Quality of Life Between Migraineurs with and without Prophylactic Medication UseGirts, T. K. / Lofland, J. H. / O Connor, J. P. et al. | 2001
- 157
-
PPN11: The Migraine in France in 2000: Epidemiological DataHenry, P. / Auray, J. P. / Duru, G. / Chazot, G. / Dartigues, J. F. / Lanteri-Minet, M. / Lucas, C. / Pradalier, A. / El Hasnaoui, A. / Gaudin, A. F. et al. | 2001
- 157
-
PPN10: Survival and Nursing Home Free Survival (NHFS) of AD PatientsWu, E. Q. / Hay, J. et al. | 2001
- 158
-
PPN13: Delays in Nursing Home Placement for Patients with Alzheimer's Disease Associated with Treatment with Donepezil May Have Health Care Cost-Saving ImplicationsProvenzano, G. / Duttagupta, S. / McRae, T. / Mastey, V. / Ellis, B. / Ieni, J. et al. | 2001
- 158
-
PPN14: A Prognostic Model to Predict Quality of Life Chances After Subarachnoid HemorrhageToth, K. / Szende, A. / Contreraz, M. / Machovich, A. / Futo, J. / Nyari, I. et al. | 2001
- 159
-
PPN17: Addressing Paradoxes in Economic Evaluations (EES). An Example Using Motor Neuron Disease (MND)Bose, U. K. / Burrell, A. / Ward, J. et al. | 2001
- 159
-
PPN16: Economic Burden and Loss in Quality of Life Due to Low Back PainSzende, A. / Lovas, K. / Szebenyi, B. / Balint, G. / Hejj, G. et al. | 2001
- 159
-
PPN15: Multiple Pain Relief Assessment in Women Undergoing Natural Versus Epidural Delivery with Ropivacain or BupivacainSzende, A. / Kincses, Z. S. / Zimanyi, M. / Kadar, Z. / Zorenyi, G. et al. | 2001
- 160
-
PPN18: Cost Savings in Migraine Associated with Less Chest Pain on New Triptan TherapyWang, J. T. / Barr, C. E. / Torigoe, Y. / Wang, E. I. / Rowland, C. R. / Goldfarb, S. D. et al. | 2001
- 160
-
PPN20: Estimated Resource Use and Cost of Mitoxantrone vs Placebo in Patients with Progressive-Relapsing and Secondary-Progressive Multiple Sclerosis: Results from the MIMS TrialDurgin, T. L. / Wanke, L. A. / Goodkin, D. / Ghalie, R. et al. | 2001
- 160
-
PPN19: Comparison of HUI2 and HUI3 Scores for Patients with Alzheimer's DiseaseNiwata, S. / Yamada, Y. / Ikeda, S. / Ikegami, N. et al. | 2001
- 170
-
PHP5: Polish Guidelines for Conducting Pharmacoeconomic Evaluations in Comparison to International Health Economic GuidelinesOrlewska, E. / Mierzejewski, P. et al. | 2001
- 170
-
PHP6: Activities, Functions and Structure of Pharmacy and Therapeutics Committees in Israeli HospitalsRotem, R. / Reuveni, H. / Goldberg, A. et al. | 2001
- 170
-
PHP7: Application of Health Economics in the Canadian Pharmaceutical IndustryHirji, Z. / Rindress, D. E. / Welner, S. A. et al. | 2001
- 171
-
PHP8: Practice Use of Pharmacoeconomics Data in Hospital Formulary DecisionsOdedina, F. T. / Sullivan, J. L. / Nash, R. / Clemmons, C. D. et al. | 2001
- 171
-
PHP10: The Potential Benefits and Drawbacks of Allowing Direct-to-Consumer Advertising of Pharmaceuticals in EuropeDickson, A. J. et al. | 2001
- 171
-
PHP9: Comparison of Technology Assessment in Large Medical Groups and Health Maintenance Organizations (HMOS)Wise, S. / Donohue, T. F. et al. | 2001
- 172
-
PHP12: Acute Care Elderly Units: Their Prevalence, Characteristics and DeterminantsJayadevappa, R. / Raziano, D. B. / Samakur, M. / Lavizzo-Mourey, R. et al. | 2001
- 172
-
PHP11: Use of the Andersen Health Care Services Utilization Behavioral Model to Understand the Relationship Between Health Insurance Coverage and Health Care Services Utilization Among the ElderlyYang, M. / Barner, J. C. et al. | 2001
- 173
-
PHP13: Indices for Evaluation of Drug Cost/Utilization: Every Silver Lining Has a Gray CloudValuck, R. J. et al. | 2001
- 173
-
PHP14: Cost Analysis of Pharmaceutical Services in a Teaching InstitutionBussieres, J. F. / Lebel, D. et al. | 2001
- 174
-
PHP17: Patient Outcomes in the Sedated ICU PatientKamath, T. / Hopefl, A. / Chaikledkaew, U. / Johnson, K. A. et al. | 2001
- 174
-
PHP15: A Survey of Public Hospital Pharmacists in Singapore on Their Views About the `Formulary' and Its Decision-Making ProcessRoy, A. / Li, S. C. et al. | 2001
- 174
-
PHP16: The Value of Various Forms of Evidence in Drug Formulary Decision MakingMorris, L. / Aikin, K. et al. | 2001
- 175
-
PHP19: Using Financial Ratios to Compare Pharmacy Spending in the Department of Veterans AffiarsSampson, J. M. et al. | 2001
- 175
-
PHP20: The Lag Between Effectiveness and Cost-Effectiveness Evidence of New Drugs and Decision-Making in Health CareStoykova, B. A. / Drummond, M. / Kleijnen, J. et al. | 2001
- 175
-
PHP18: A Model for Comparing Costs Associated with Prescription Wastage with Application to VA Prescription DataWalton, S. M. / Johnson, N. E. / Arondekar, B. V. / Schumock, G. T. et al. | 2001
- 176
-
PHP21: Single European-Level Cost-Effectiveness Analysis: Over the Fourth Hurdle and into the Ditch?Hutton, J. / Nuijten, M. / Chambers, M. et al. | 2001
- 176
-
PHP23: Drug Reimbursement Program for Indigent Patients: An Economic Impact on the Hospital Administration BudgetNguyen, A. B. / Arbuckle, R. / Anderson, R. W. / Sansgiry, S. S. et al. | 2001
- 176
-
PHP22: Patient Adherence to Drug Therapy in a Three-Tier Copayment StructureHutchison, S. et al. | 2001
- 177
-
PQP1: Lessons Learned from Developing a Psychometrically Based Sedation Questionnaire in Pharmacologically Paralyzed Critically Ill PatientsKane, S. L. / Dasta, J. F. / Pathak, D. S. et al. | 2001
- 177
-
PQP2: Role of Health-Related Quality of Life Outcomes in the European Drug Regulatory Process: A Review of the EMEA DocumentsAcquadro, C. / Staniek, V. / ERIQA Group et al. | 2001
- 178
-
PQP4: Cross-Cultural Variations in SF-12 Scores Among Individuals with Various Health ConditionsBolge, S. C. / Eschmann, B. / Donohue, J. A. et al. | 2001
- 178
-
PQP5: Translating SF-36 Scores into Preferences: An Examination of the Performance of Two Predictive EquationsMeletiche, D. M. / Roberts, C. S. / Lofland, J. H. et al. | 2001
- 178
-
PQP3: Defining Clinically Meaningful Change in Health-Related Quality of LifeCrosby, R. D. / Kolotkin, R. L. / Williams, G. R. et al. | 2001
- 179
-
PQP8: Evaluating Bias Introduced by Annualizing Utilization and Cost MeasuresZodet, M. / de Lissovoy, G. et al. | 2001
- 179
-
PQP6: Health Utilities Index Mark 3: Agreement Between Raters and Between Modalities of AdministrationVerrips, G. / den Ouden, A. / Bonsel, G. / Gemke, R. / Paneth, N. / Verloove-Vanhorick, S. et al. | 2001
- 179
-
PQP7: Is Compliance with Drug Treatment Correlated with Health Related Quality of Life?Cote, I. / Farris, K. B. / Feeny, D. H. et al. | 2001
- 180
-
PQP9: Quality of Life Patients with Fabry DiseaseBotteman, M. F. / Pastores, G. M. / Gold, K. F. / Yeh, J. / Ali, J. / Aliski, W. / Pashos, C. L. et al. | 2001
- 180
-
PQP10: Negative Affectivity: A Significant Contaminant of Patient Reported Health Related Quality of Life Instruments (SF-36)Reed, P. J. / Moore, D. D. et al. | 2001
- 181
-
PQP11: The Health and Work Questionnaire (HWQ): An Instrument for Assessing Workplace Productivity in Relation to Worker HealthShikiar, R. / Rentz, A. M. / Halpern, M. T. / Khan, Z. M. et al. | 2001
- 181
-
PMA1: Methodological Advances in the Assessment of Quality of Life in Clinical TrialsHufford, M. R. et al. | 2001
- 182
-
PMA3: Does Where You Life Affect If and How You Discount Future Costs and Benefits in Economic Evaluation? Should It?Faulkner, L. A. / Gafni, A. / O Brien, B. J. et al. | 2001
- 182
-
PMA2: Development of Cost-Effective Web-Based Outcomes Research Studies and Disease Management ProgramsAmbegaonkar, A. J. / Day, D. et al. | 2001
- 182
-
PMA4: An Economic Proof and Application That Formulary Restrictions Within Drug Classes Always Result in Higher CostsSimons, W. R. et al. | 2001
- 183
-
PMA5: A Risk Adjustment Methodology for Claims DataWilson, P. / Yuan, Y. / Dowse, B. T. et al. | 2001
- 183
-
PMA7: Controlling for Biases from Measurement Errors in Health Outcomes Research Using Structural Equation ModelingShi, J. / McCombs, J. / Hay, J. / Nichol, M. / Chou, C. P. / Hsiao, C. et al. | 2001
- 183
-
PMA6: The Reduction of Sample Size for a Cost-Effectiveness Trial Using a New Method: The Eight Cases in JapanKamae, I. / Yanagisawa, S. et al. | 2001
- 184
-
PMA8: Development of a Chronic Disease Indicator Using a Managed Care PopulationMalone, D. C. / Raebel, M. A. et al. | 2001
- 184
-
PMA9: Bayesian or Classical Design and Analysis: Does It Make a Difference?Bloom, B. S. et al. | 2001
- 185
-
PMA10: Description of Cost/Effectiveness Ratio DistributionsKim, S. / Moeschberger, M. / Pathak, D. et al. | 2001
- 185
-
PMA11: Comparison of Statistical Tests for the Cost/Effectiveness RatiosKim, S. / Moeschberger, M. / Pathak, D. et al. | 2001
- 185
-
PMA12: Relationship Between Nonparametric Receiver Operating Characteristic Analysis and a Likelihood-Ratio test for Model Selection: 1. A Monte Carlo Simulation Using Continuous DataShaw, J. W. / Horrace, W. / Coons, S. J. et al. | 2001
- 186
-
PMA13: Relationship Between Nonparametric Receiver Operating Characteristic Analysis and a Likelihood-Ratio Test for Model Selection: II. A Monte Carlo Simulation Using Discrete DataShaw, J. W. / Shahriar, J. / Horrace, W. et al. | 2001
- 186
-
PMA14: Bayesian Decision Analysis in Outcome Studies with Small Numbers of Events: A Simulation Based Prediction ApproachWang, J. / Davey, P. / MacDonald, T. et al. | 2001
- 187
-
PMA17: The European Service Mapping Schedule (ESMS): A New Instrument for Mental Health Services Research, Results of a French StudyAzorin, J. M. / Goudemand, M. / Toumi, M. / Johnson, S. / Pettersson, A. et al. | 2001
- 187
-
PMA15: Conducting Pharmacoeconomic Research in the Absence of Country-Specific DataMiller, B. / Rosner, A. J. / Becker, D. L. et al. | 2001
- 187
-
PMA16: Confirmation of the Decision Rules and Assumptions for a Model of Diabetes Treatment Using an Expert PanelCaro, J. / Salas, M. / Ward, A. / Sung, J. / Shah, A. et al. | 2001
- 188
-
PMA18: The Avandia Worldwide Awareness Registry (AWARE®): An Internet-Based Program for Evaluation of Clinical, Humanistic and Economic Outcomes of Patients with Type 2 DiabetesBakst, A. / Meletiche, D. M. / Arnold, R. / Harjono, H. / Najib, M. / Cobitz, A. et al. | 2001
- 188
-
WW1: Methodological Complexities in Using Administrative Claims Databases to Evaluate Quality of Care for Attention-Deficit/Hyperactivity DisorderHankin, C. S. / Wright, A. T. et al. | 2001
- 189
-
WW2: Using Linkable Clinical and Administrative Claims Data to Improve Outcomes Research: Selected Case Studies from Oncology and Diabetes MellitusMenzin, J. / Lang, K. et al. | 2001
- 189
-
WW4: A New Approach to Disease Modeling with Numerous Comparators and Multiple Decision TreesBecker, R. / Noe, L. / Gore, M. / Martino, S. et al. | 2001
- 189
-
WW3: Issues and Problems Encountered in Models on Prevention of Deep Venous Thrombosis (DVT)Annemans, L. / Lamotte, M. / Huybrechts, M. et al. | 2001
- 190
-
WW5: Creative Approaches to Modeling Life Expectancy Gains for Economic Evaluation Using Published DataWeinstein, M. C. / Appadoo, S. et al. | 2001
- 190
-
WW6: Conducting Cost-Benefit and Cost-Utility Analysis: A Conjoint Analysis ApproachHauber, A. B. / Bala, M. V. / Fehnel, S. E. et al. | 2001
- 191
-
WW7: Beyond Cost-Effectiveness: The Strategic Value of Productivity-Related Outcomes in Clinical Trials, Burden of Illness Studies, and Post-Marketing ResearchOzminkowski, R. J. / Goetzel, R. Z. / Crown, W. C. / Long, S. R. / Ling, D. et al. | 2001
- 191
-
WW8: Constructing Episodes of Care from Claims Data: Applications to Pharmacoeconomic and Outcomes ResearchHuse, D. / Portnoy, M. et al. | 2001
- 192
-
WW10: Multinational Economic Studies: Lessons Learned from Trial-Based and Modelling StudiesDrummond, M. F. / Grima, D. et al. | 2001
- 192
-
WW9: The Use of Multi-Attribute Analysis and Pair-Wise Comparisons for Group Decision-MakingHess, G. P. / Forman, E. et al. | 2001
- 192
-
WW11: Using Markov Decision Models to Develop Optimal Treatment Pathways: An IllustrationBala, M. V. / Mauskopf, J. A. et al. | 2001
- 193
-
WW13: Challenges in Performing Meta Analysis in Heart Failure Outcomes ResearchMullins, C. D. / Weiss, S. / Fulda, T. et al. | 2001
- 193
-
WW14: Making Models BetterMatchar, D. B. / Samsa, G. P. / Parmigiani, G. et al. | 2001
- 193
-
WW12: Use of Medication Compliance Data in Outcome AnalysesCramer, J. A. / Urquhart, J. et al. | 2001
- 194
-
WW15: Identifying the Impact of a Treatment on Outcomes and Costs Using Observational Data: Overcoming Selection BiasPolsky, D. / Glick, H. A. et al. | 2001
- 194
-
WW16: Patient Registries: Their Value in Outcomes ResearchRussell, M. W. et al. | 2001
- 195
-
WW18: The Role of Health State Experience in Longitudinal Conjoint Analysis of Patient PreferencesBingham, M. / Smith, G. et al. | 2001
- 195
-
WW17: Selecting Health-Related Quality-of-Life Measures: First PrinciplesErickson, P. et al. | 2001